Barclays PLC Increases Position in DocGo Inc. (NASDAQ:DCGO)

Barclays PLC lifted its stake in DocGo Inc. (NASDAQ:DCGOFree Report) by 279.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 134,923 shares of the company’s stock after purchasing an additional 99,387 shares during the period. Barclays PLC owned approximately 0.13% of DocGo worth $447,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Harbor Capital Advisors Inc. lifted its position in shares of DocGo by 144.6% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 968,537 shares of the company’s stock valued at $3,216,000 after acquiring an additional 572,522 shares during the period. Marshall Wace LLP boosted its position in DocGo by 212.4% during the second quarter. Marshall Wace LLP now owns 505,514 shares of the company’s stock worth $1,562,000 after purchasing an additional 343,692 shares in the last quarter. State Street Corp grew its holdings in DocGo by 4.9% in the third quarter. State Street Corp now owns 1,928,972 shares of the company’s stock valued at $6,404,000 after purchasing an additional 90,438 shares during the last quarter. Deerfield Management Company L.P. Series C grew its holdings in DocGo by 41.0% in the second quarter. Deerfield Management Company L.P. Series C now owns 7,195,956 shares of the company’s stock valued at $22,236,000 after purchasing an additional 2,091,569 shares during the last quarter. Finally, Intech Investment Management LLC purchased a new position in shares of DocGo in the third quarter valued at $62,000. Hedge funds and other institutional investors own 56.44% of the company’s stock.

Analyst Ratings Changes

Separately, Cantor Fitzgerald reissued an “overweight” rating and issued a $5.00 price objective on shares of DocGo in a research note on Friday, September 20th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, DocGo has an average rating of “Buy” and a consensus target price of $6.10.

Read Our Latest Report on DCGO

DocGo Stock Up 1.2 %

Shares of NASDAQ:DCGO opened at $4.34 on Friday. The company has a market capitalization of $442.90 million, a P/E ratio of 15.50, a P/E/G ratio of 3.94 and a beta of 0.98. The stock’s fifty day simple moving average is $4.11 and its 200-day simple moving average is $3.61. DocGo Inc. has a 52-week low of $2.75 and a 52-week high of $5.19.

Insider Buying and Selling at DocGo

In other DocGo news, General Counsel Ely D. Tendler sold 23,088 shares of the business’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $4.44, for a total value of $102,510.72. Following the completion of the transaction, the general counsel now directly owns 175,645 shares in the company, valued at approximately $779,863.80. The trade was a 11.62 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 2.70% of the stock is owned by insiders.

About DocGo

(Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Featured Articles

Institutional Ownership by Quarter for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.